Tested albuterol inhaler compared to a standard inhaler for mild asthma
Part of Lungs & breathing clinical trials.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of mild asthma and it’s been documented in the past.
- Your asthma has been stable for at least 1 month using only low-dose inhaled steroid (with or without as-needed rescue reliever).
- Your breathing test is good: your FEV1 is at least 80% of the expected value after you stop rescue inhaler for at least 8 hours.
- You must be responsive to a bronchial challenge test (methacholine PC20 at or below 8 mg/mL before albuterol).
- You haven’t had a breathing infection in the last 6 weeks and you’re otherwise generally healthy (no other lung diseases).
- You can use an inhaler correctly, will follow birth-control rules if needed, and will not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This trial tests whether a new combination inhaler works as well as a commonly used one for teenagers with asthma that is not well controlled. It aims to find a safe and effective treatment option for adolescents.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
Hear when a new Mild Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.